Related references
Note: Only part of the references are listed.Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell et al.
BRAIN (2011)
The molecular basis of neurodegeneration in multiple sclerosis
Hans Lassmann et al.
FEBS LETTERS (2011)
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Lars Bornsen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Age and disability accumulation in multiple sclerosis
A. Scalfari et al.
NEUROLOGY (2011)
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
M. S. Freedman et al.
NEUROLOGY (2011)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
M. Khademi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F. Sellebjerg et al.
NEUROLOGY (2009)
Progressive multiple sclerosis
Monika Bradl et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis
Manjit Braitch et al.
ARCHIVES OF NEUROLOGY (2008)
Perivascular Spaces and the Two Steps to Neuroinflammation
Trevor Owens et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Widespread demyelination in the cerebellar cortex in multiple sclerosis
Alexandra Kutzelnigg et al.
BRAIN PATHOLOGY (2007)
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
Eun Mi Hur et al.
NATURE IMMUNOLOGY (2007)
Secondary progressive multiple sclerosis: current knowledge and future challenges
M Rovaris et al.
LANCET NEUROLOGY (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Up-regulation of osteopontin and αΒ-crystallin in the normal-appearing white matter of multiple sclerosis:: an immunohistochemical study utilizing tissue microarrays
C Sinclair et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study
A Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Primary progressive multiple sclerosis - Current and future treatment options
SM Leary et al.
CNS DRUGS (2005)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis
AI Danilov et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis
F Sellebjerg et al.
MULTIPLE SCLEROSIS (2003)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
RLP Lindberg et al.
BRAIN (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Relapses and progression of disability in multiple sclerosis.
C Confavreux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Multiple sclerosis and chronic autoimmune encephalomyelitis -: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
B Kornek et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis
F Sellebjerg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2000)